Advertisement

Topics

Lonza to Expand HPAPI Development and Manufacturing Capacity

03:58 EDT 14 Jun 2019 | Contract Pharma

Will develop new facilities at Visp site; enters long term mfg. agreement with AstraZeneca

Original Article: Lonza to Expand HPAPI Development and Manufacturing Capacity

NEXT ARTICLE

More From BioPortfolio on "Lonza to Expand HPAPI Development and Manufacturing Capacity"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...